Literature DB >> 3497050

Prostaglandin E acts at two levels to enhance colony formation in vitro by erythroid (BFU-E) progenitor cells.

L Lu, L M Pelus, W Piacibello, M A Moore, W Hu, H E Broxmeyer.   

Abstract

The prostaglandin E (PGE) enhancement of erythroid colony formation by human bone marrow erythroid progenitor cells (BFU-E) is mediated by a T8+ subset of lymphocytes. Medium was conditioned by bone marrow and blood T-lymphocytes and T-lymphocyte subsets (T8+, T8-, T4+, and T4- cells) in the absence or presence of PGE1 in order to determine if the cells could release a cell-free source of erythroid colony enhancing activity and what the conditions for this release would be. The T-lymphocyte conditioned medium was assayed for its effects on erythroid colony formation by nonadherent low-density T-lymphocyte depleted (NALT-) bone marrow cells plated in the presence of erythropoietin, hemin, phytohemagglutinin-stimulated leukocyte conditioned medium, or medium conditioned by 5637 cells, in the absence or presence of PGE1 and in the presence or absence of serum. PGE1 induced the release of an erythroid colony enhancing activity from the T8+ and T4-, but not from the T8- and T4+ subsets of lymphocytes, but this cell-free source of activity was only apparent if it was tested for colony formation in the presence of added PGE1. The release and action of the PGE1 induced T-lymphocyte erythroid enhancing activity did not require the presence of serum. Erythroid colony formation by NALT- bone marrow cells was not enhanced by PGE1 alone, by medium conditioned by T-lymphocytes in the absence of PGE1, or by PGE1 plus medium conditioned by T-lymphocytes in the absence of PGE1. The results suggest that the PGE1 enhancement of erythroid colony formation occurs by an apparently synergistic action on non-T-lymphocytes by PGE1 itself and by a factor or factors released from T8+ lymphocytes in response to PGE1.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3497050

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  11 in total

Review 1.  Pleiotropic effects of prostaglandin E2 in hematopoiesis; prostaglandin E2 and other eicosanoids regulate hematopoietic stem and progenitor cell function.

Authors:  Louis M Pelus; Jonathan Hoggatt
Journal:  Prostaglandins Other Lipid Mediat       Date:  2011-06-21       Impact factor: 3.072

2.  Inhibition of DPP4/CD26 and dmPGE₂ treatment enhances engraftment of mouse bone marrow hematopoietic stem cells.

Authors:  Hal E Broxmeyer; Louis M Pelus
Journal:  Blood Cells Mol Dis       Date:  2014-03-03       Impact factor: 3.039

3.  Blockade of prostaglandin E2 signaling through EP1 and EP3 receptors attenuates Flt3L-dependent dendritic cell development from hematopoietic progenitor cells.

Authors:  Pratibha Singh; Jonathan Hoggatt; Peirong Hu; Jennifer M Speth; Seiji Fukuda; Richard M Breyer; Louis M Pelus
Journal:  Blood       Date:  2011-11-22       Impact factor: 22.113

Review 4.  Eicosanoid regulation of hematopoiesis and hematopoietic stem and progenitor trafficking.

Authors:  J Hoggatt; L M Pelus
Journal:  Leukemia       Date:  2010-09-30       Impact factor: 11.528

5.  Meloxicam with Filgrastim may Reduce Oxidative Stress in Hematopoietic Progenitor Cells during Mobilization of Autologous Peripheral Blood Stem Cells in Patients with Multiple Myeloma.

Authors:  Andrea M Patterson; Shuhong Zhang; Liqiong Liu; Hongge Li; Pratibha Singh; Yunlong Liu; Sherif S Farag; Louis M Pelus
Journal:  Stem Cell Rev Rep       Date:  2021-09-12       Impact factor: 5.739

6.  Prostaglandin E2 enhances hematopoietic stem cell homing, survival, and proliferation.

Authors:  Jonathan Hoggatt; Pratibha Singh; Janardhan Sampath; Louis M Pelus
Journal:  Blood       Date:  2009-03-26       Impact factor: 22.113

Review 7.  Leukemia and ABC transporters.

Authors:  Yu Fukuda; Shangli Lian; John D Schuetz
Journal:  Adv Cancer Res       Date:  2015-01-08       Impact factor: 5.767

Review 8.  Pharmacological Modulation of Radiation Damage. Does It Exist a Chance for Other Substances than Hematopoietic Growth Factors and Cytokines?

Authors:  Michal Hofer; Zuzana Hoferová; Martin Falk
Journal:  Int J Mol Sci       Date:  2017-06-28       Impact factor: 5.923

9.  Prostaglandin E2 Regulates Bipotent Monocyte-Dendritic Progenitor Cell Lineage-Commitment.

Authors:  Pratibha Singh; Louis M Pelus
Journal:  Stem Cell Rev Rep       Date:  2021-06-22       Impact factor: 5.739

10.  Transforming growth factor beta 1 is an inducer of erythroid differentiation.

Authors:  G Krystal; V Lam; W Dragowska; C Takahashi; J Appel; A Gontier; A Jenkins; H Lam; L Quon; P Lansdorp
Journal:  J Exp Med       Date:  1994-09-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.